Navigation Links
Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at,the Fourth International Conference on Tumor Microenvironment in,Florence, Italy

mor Microenvironment conference website, and the reference to such website in this News Release does not constitute an endorsement by Helix of that or any other website. This News Release contains certain forward-looking statements regarding potential cancer therapeutics under development by the Company, and in particular, regarding L-DOS47. Forward-looking statements can be identified by the use of forward-looking terminology such as "potential", "is thought", "is believed", "new", "will", "theorized", or variations thereon or comparable terminology referring to future events or results.

Forward looking statements are statements about the future and are inherently uncertain, and Helix's
actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including without limitation, uncertainty whether L-DOS47 will be developed successfully as a drug or at all; uncertainty whether DOS47 will be developed as a therapeutic for any other cancers; research & development risks, including the risk that early R&D results may not be repeated in later R&D; the risk of technical obsolescence; the need for regulatory approvals, which may not be obtained in a timely matter or at all; the need for clinical trials, the occurrence and success of which cannot be assured; intellectual property risks; marketing/manufacturing and partnership/strategic alliance risks; the effect of competition; Helix's need for additional future capital, which may not be available in a timely manner or at all, as well as a description of other risks and uncertainties affecting Helix and its business, as contained in Helix's latest Annual Information Form and other filings with the Canadian
Securities Regulatory Authorities at www.sedar.com, any of which could cause actual results to vary materially from current results or Helix's anticipated future re
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
2. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
5. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
8. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
9. The Past, Present and Future of HLA Typing
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
(Date:8/28/2015)... England and PITTSBURGH ... MYL ) today announced that its shareholders ... plc (NYSE: PRGO ; TASE) and the ... shareholders at an extraordinary general meeting of shareholders ... the votes cast at the extraordinary general meeting. ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... Reportlinker.com announces that a new market research ... Global Pico Projector By Application, Technology ... http://www.reportlinker.com/p0304770/Global-Pico-Projector-By-Application-Technology--Products-Market-2010-2014.html REPORT ... revolutionize the global projector market by making projectors ...
... Sept. 28 Today Governor Deval Patrick and Massachusetts ... state and local officials, Organogenesis, Inc. CEO Geoff MacKay ... new headquarters building at 85 Dan Road in Canton. ... announcing that its Apligraf®  living cell based product has ...
Cached Medicine Technology:Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014) 2Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014) 3Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014) 4Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014) 5Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014) 6Governor Patrick, Life Sciences Center Celebrate Organogenesis' New Headquarters 2Governor Patrick, Life Sciences Center Celebrate Organogenesis' New Headquarters 3Governor Patrick, Life Sciences Center Celebrate Organogenesis' New Headquarters 4
(Date:8/28/2015)... ... 28, 2015 , ... Approximately 2,000 United Methodists are expected ... helping children, a thank you to the many creative and generous ways in ... United Methodist initiative to end malaria deaths. , The Columbus Zoo and Aquarium ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews and ... workshop, chaired by internationally renowned expert Fubin Wu, has been specifically designed ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Veterans Award, honoring military veterans leading in business. Mr. Troy Mizell, Chairman ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists ... teeth whitening. For just $199, patients can currently receive a one hour treatment of ... whitening procedures, but it includes a number of unique features that can turn teeth ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... 30 Few spices are as,treasured and avoided! A ... you eat it, don,t be surprised if even your ... few people find the smell of garlic disgusting, and,will ... Reporter answers questions of our Podcast listeners on Chemistry,in ...
... Intuitive Surgical and ATS Medical, MINNEAPOLIS, April ... manufacturer and marketer of state-of-the-art cardiac,surgery products and ... to be held at the American Association for ... is the first in a series,of meetings intended ...
... Services, Inc.,(NYSE: CSV ) today announced plans to release 2008 ... with the release,Carriage Services has scheduled a conference call, which will ... 10:30 a.m. eastern time., What: Carriage Services ... May 9, 2008 -- 10:30 a.m. eastern time, How: ...
... 29 Mylan Inc. (NYSE: MYL ),today announced ... the Company has declared its quarterly dividend of $16.25 ... and a liquidation,preference of $1,000.00 per share) payable on ... as of May 1, 2008., Mylan Inc., with ...
... April 29 George W. Crabtree, a senior,scientist and ... Laboratory, was elected a member of the National Academy,of ... in the NAS is one of the highest honors ... Crabtree will be inducted into the Academy,next April during ...
... of Donate Life Month, Caucus Seeks to Raise ... April 29, 2008, members of the,American Society of ... of Organ Procurement Organizations, National,Kidney Foundation, and Donate ... recognition of Donate Life Month. April is Donate,Life ...
Cached Medicine News:Health News:BASF Podcast: The Chemical Reporter - Why do You Get Garlic Breath? 2Health News:ATS Medical Announces First 'Frontiers in Cryoablation' Symposium 2Health News:ATS Medical Announces First 'Frontiers in Cryoablation' Symposium 3Health News:ATS Medical Announces First 'Frontiers in Cryoablation' Symposium 4Health News:Carriage Services Announces First Quarter Earnings Release and Conference Call Schedule 2Health News:Argonne's Crabtree Elected to National Academy of Sciences 2Health News:Congressional Organ and Tissue Donation Awareness Caucus Hosted Congressional Staff Meeting on April 29 to Spread the Truth About Organ Donation 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: